Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents
Open Access
- 12 September 2011
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 48 (9), 1407-1413
- https://doi.org/10.1016/j.ejca.2011.08.009
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (21590285, 22590242)
This publication has 27 references indexed in Scilit:
- Oxaliplatin-induced neuropathy in the rat: Involvement of oxalate in cold hyperalgesia but not mechanical allodyniaPain, 2009
- Oxaliplatin-related neurotoxicity: How and why?Critical Reviews in Oncology/Hematology, 2006
- OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer—A GERCOR StudyJournal of Clinical Oncology, 2006
- Prevention of Oxaliplatin-Related Neurotoxicity by Calcium and Magnesium InfusionsClinical Cancer Research, 2004
- Clinical aspects and molecular basis of oxaliplatin neurotoxicity: Current management and development of preventive measuresSeminars in Oncology, 2002
- Oxaliplatin-related side effects: Characteristics and managementSeminars in Oncology, 2002
- Acute Oxaliplatin-Induced Peripheral Nerve HyperexcitabilityJournal of Clinical Oncology, 2002
- Chemotherapy-induced peripheral neuropathyZeitschrift für Neurologie, 2002
- Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal CancerJournal of Clinical Oncology, 2000
- Oxaliplatin in practiceBritish Journal of Cancer, 1998